{"name":"Elizabeth Anne Thiele","slug":"elizabeth-anne-thiele","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPTkRaeXJIQkF5MFNoUHZMZG9YMy14ODMtTHpWRUJycktldy12WFpIWW1BZ1ljV2x6TWRqdFBVVkxDX0lLc1l5MXMzbVlkMEVvTmFzLXZsMWdtaks0eVg5ZUNFQ21ma1pLTTFzSmc5VkNiZkl4T05aZjVjTTNDLTdzLXh3bzdFQkVTVXNxYkJiQ01sWVZpUkRNbWYtM1BUU19fckE?oc=5","date":"2025-12-13","type":"trial","source":"neurologylive.com","summary":"Beyond Dravet and LGS: Elizabeth Thiele, MD, PhD, on New Data for Epidiolex in DEEs - neurologylive.com","headline":"Beyond Dravet and LGS: Elizabeth Thiele, MD, PhD, on New Data for Epidiolex in DEEs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBzOUZ6LTBmZGIyTGgtMVZ1LVNFUWlCSy1hcXB0eUJNQTZndHdHZ05Od0lSUGtxYkhqMVpqc256dWJYREtHMjUyRlpyWV9TcHJfLUNSY3I5aHZHLWZqMmpkb1VOdFJSMDlZelE?oc=5","date":"2025-03-12","type":"pipeline","source":"Wiley Online Library","summary":"Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome - Wiley Online Library","headline":"Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBObGlvajBscHlnSFFfYU91UDl2Y1B2b250bk4zZUJudG4waWxOalQ5OXlpWEVEUTZnYVNfSnZsVGQ3RW8zM3hkUVhlSnE5OXdQd21yc09Xck4yN1VWUmx5M2c0c19hekkxQkNGTg?oc=5","date":"2024-06-21","type":"pipeline","source":"Wiley Online Library","summary":"Comprehensive scoping review of fenfluramine's role in managing generalized tonic–clonic seizures in developmental and epileptic encephalopathies - Wiley Online Library","headline":"Comprehensive scoping review of fenfluramine's role in managing generalized tonic–clonic seizures in developmental and e","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1sYVB1QS1mODFZY01vNGI5QjY1MmpTTHVhQm8tMmZnNWh2WEdwV0xtdURoQk9MVm4wYVJfZm9JMzVZTGlkUVFxZEN6MFRxU1dCMFNabkNDaXY2SjNQNGFaZWt1bFlMQWtpWkE?oc=5","date":"2023-12-10","type":"trial","source":"Neurology® Journals","summary":"Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome - Neurology® Journals","headline":"Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome - Neurology® Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOcEp2STJoY0Zqc2NQM2VoRVVQd3J4ZE5fald3NzMycEg0UTNxWEpsaFh0dVhYOEI4d3RxSTJGTENkbHQ5VUhIU0JYYmlJRUxTS0RTSGdHUWt1eEhfQmFKN2lRZnJyZXR4cFoxckxySmVtaFM0OUVHRUFDYUxqMng5WnFnWWxPeFpPS2lodEx2eWI0eTFXcU9QaGFjSTVHOGF4NkVEcVR5TG9PQQ?oc=5","date":"2021-12-03","type":"regulatory","source":"neurologylive.com","summary":"Cannabidiol’s Approval on Dravet and Lennox-Gastaut Syndromes Continued - neurologylive.com","headline":"Cannabidiol’s Approval on Dravet and Lennox-Gastaut Syndromes Continued","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNRllmOWFOQk1ockN5eS1DWE1pdkRUN1Q2eXAwX2hjd1pKN2RBeU9oc25iTWc0WGYwbnBST05NZnlUREtmd3NQczljdDRHNDVNOGFzeks1M295VjFjSGk5UXMweTdlYzlTZm9KNjR2eUhQRkxhaXRNQl91dlowdWRoOTR1U3R5WldTZDhqdlR4UF8tNXhVc2NIQTJNcFBMQQ?oc=5","date":"2020-04-08","type":"pipeline","source":"neurologylive.com","summary":"Treating Tuberous Sclerosis: A Time to Shine for a Rare Disease - neurologylive.com","headline":"Treating Tuberous Sclerosis: A Time to Shine for a Rare Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE5GQ09fREZqeHNQc2FuUEVId2d0bFFUWHRtVmhDaDFrM3NFZVItTUlwYVdnaklXLVBnbWxaQkluMjd5el9oNTRUa19SQ2pHSHRFUTV6bDFleC1SUl9KOUprNg?oc=5","date":"2017-05-25","type":"trial","source":"NEJM","summary":"Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome - NEJM","headline":"Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}